Advertisement

Topics

Alzeca Biosciences closes $11mm Series A round

15:40 EDT 22 Aug 2017 | Elsevier Business Intelligence

Neurodegenerative disease-focused Alzeca Biosciences Inc. (MRI-based targeted contrast agents to diagnose early-stage Alzheim...

Original Article: Alzeca Biosciences closes $11mm Series A round

NEXT ARTICLE

More From BioPortfolio on "Alzeca Biosciences closes $11mm Series A round"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Radiology
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...